ストックスクリーナーアプリを入手
268.54
0.54%
-1.46
アフターアワーズ：
268.28
-0.26
-0.10%
前日終値:
$270.00
開ける：
$270.01
24時間の取引高:
246.24K
Relative Volume:
0.85
時価総額：
$7.90B
収益：
$389.13M
当期純損益:
$204.83M
株価収益率:
39.24
EPS:
6.8443
ネットキャッシュフロー:
$188.91M
1週間 パフォーマンス:
+1.64%
1か月 パフォーマンス:
+8.61%
6か月 パフォーマンス:
+39.15%
1年 パフォーマンス:
+58.78%
1日の値動き範囲:
$262.40
$271.05
1週間の範囲:
$252.30
$275.75
52週間の値動き範囲:
$122.80
$298.30
Krystal Biotech Inc Stock (KRYS) Company Profile
名前
Krystal Biotech Inc
セクター
電話
(412) 586-5830
住所
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
268.54 | 7.95B | 389.13M | 204.83M | 188.91M | 6.8443 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | Wolfe Research | Peer Perform |
| 2026-01-06 | アップグレード | Citigroup | Neutral → Buy |
| 2025-03-05 | 開始されました | Jefferies | Buy |
| 2024-08-06 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 開始されました | Citigroup | Buy |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-18 | 開始されました | Stifel | Buy |
| 2023-02-28 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
| 2022-01-18 | 開始されました | BofA Securities | Buy |
| 2021-07-20 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-18 | 開始されました | B. Riley FBR | Buy |
| 2020-06-04 | 開始されました | Evercore ISI | Outperform |
| 2019-09-24 | 開始されました | Goldman | Neutral |
| 2019-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-24 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-06-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-05-30 | 開始されました | Guggenheim | Buy |
| 2018-09-11 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Krystal Biotech Inc (KRYS) 最新ニュース
Krystal Biotech Inc stock (US5012681064): Is its gene therapy pipeline strong enough to unlock new u - AD HOC NEWS
Book value per share of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets
Total equity of Krystal Biotech Inc Unsponsored BDR – BMFBOVESPA:K1YS34 - TradingView — Track All Markets
Krystal Biotech (HAM:4KB) Cyclically Adjusted Price-to-FCF : (As of Apr. 11, 2026) - GuruFocus
Krystal Biotech (NASDAQ:KRYS) - intelligentinvestor.com.au
Price-Driven Insight from (KRYS) for Rule-Based Strategy - Stock Traders Daily
Krystal Biotech (HAM:4KB) Gross Property, Plant and Equipment : €161.7 Mil (As of Dec. 2025) - GuruFocus
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Krystal Biotech Inc Phase 1/2 Clinical Trial of KB103 Final Update Call Transcript - GuruFocus
Krystal Biotech Inc (HAM:4KB) Competitors 2026 - GuruFocus
Krystal Biotech (HAM:4KB) Net Income (Continuing Operations) : €177.8 Mil (TTM As of Dec. 2025) - GuruFocus
Krystal Biotech Inc (HAM:4KB)Valuation Measures & Financial Statistics - GuruFocus
Krystal Biotech Inc (HAM:4KB) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Krystal Biotech Inc (HAM:4KB) Dividend - GuruFocus
Krystal Biotech Inc (HAM:4KB) Stock Price & 30 Year Financial Data - GuruFocus
Who's Buying or Selling Krystal Biotech Inc (HAM:4KB) Stock Today? - GuruFocus
Krystal Biotech Inc Stock Operating Data - GuruFocus
Krystal Biotech Inc (HAM:4KB) Valuation - GuruFocus
Krystal Biotech Inc (HAM:4KB) Stock News, Headlines & Updates - GuruFocus
Krystal Biotech Inc (HAM:4KB) Stock Earnings Transcripts - GuruFocus
Krystal Biotech Inc (HAM:4KB) Stock Price, Trades & News - GuruFocus
KRYS Technical Analysis | Trend, Signals & Chart Patterns | KRYSTAL BIOTECH INC (NASDAQ:KRYS) - ChartMill
BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $325 - Moomoo
Layoff Watch: Can Krystal Biotech Inc weather a recession2026 PreEarnings & Fast Gain Stock Trading Tips - baoquankhu1.vn
Could This Under-the-Radar Healthcare Stock Set You Up for Life? - AOL.com
KRYS | Krystal Biotech, Inc. Common Executive Compensation - Quiver Quantitative
Krystal Biotech, Inc. ($KRYS) CEO 2025 Pay Revealed - Quiver Quantitative
KRYS PE Ratio & Valuation, Is KRYS Overvalued - Intellectia AI
Krystal Biotech, Inc. (KRYS) Stock forecasts - Yahoo Finance UK
[DEF 14A] Krystal Biotech, Inc. Definitive Proxy Statement - Stock Titan
SG Americas Securities LLC Purchases 15,591 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
3 Insider-Owned Growth Companies With Up To 81% Earnings Expansion - simplywall.st
KRYS News & Events - intellectia.ai
BSP:K1YS34 PB Ratio: 0.20 — 96% Below Median - GuruFocus
Exploring Three High Growth Tech Stocks In The US Market - simplywall.st
(KRYS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Krystal Biotech stock price forecast: consolidation likely as KRYS hovers near key support and down 2.39% - Traders Union
Assessing Krystal Biotech (KRYS) Valuation After Recent Share Price Weakness - finance.yahoo.com
Krystal Biotech (NASDAQ:KRYS) Coverage Initiated at Wolfe Research - Defense World
Krystal Biotech (BSP:K1YS34) Cyclically Adjusted PB Ratio : (As of Apr. 01, 2026) - GuruFocus
Krystal Biotech (BSP:K1YS34) EBITDA per Share : R$30.92 (TTM As of Dec. 2025) - GuruFocus
Krystal Biotech (BSP:K1YS34) Gross Property, Plant and Equipment : R$1,033 Mil (As of Dec. 2025) - GuruFocus
Krystal Biotech (BSP:K1YS34) Minority Interest : R$0.00 Mil (As of Dec. 2025) - GuruFocus
Q3 2024 Krystal Biotech Inc Earnings Call Transcript - GuruFocus
Krystal Biotech Inc (BSP:K1YS34) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Krystal Biotech (BSP:K1YS34) Shiller PE Ratio : (As of Mar. 28, 2026) - GuruFocus
BSP:K1YS34 Pretax Margin %: 47.74% — 45% Above Median - GuruFocus
Krystal Biotech (BSP:K1YS34) Unearned Premiums - GuruFocus
BSP:K1YS34 Graham Number: R$439.15 — 14786% Above Median - GuruFocus
Krystal Biotech Inc (BSP:K1YS34) Dividend - GuruFocus
Krystal Biotech Inc FDA Approval Call Transcript - GuruFocus
Krystal Biotech Inc (KRYS) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):